Highlights

• 

  • 18 June 2021
  • HBS Health Care Initiative

  Recent Webinar: Perspectives in Health: Brainlab - The Surgical Suite of the Future

  Professor Regina Herzlinger and Stefan Vilsmeier, CEO of Brainlab, recently discussed innovation in MedTech as well as trends and the future of the industry. Listen in on their insights shared.
• 

  • 16 June 2021
  • HBS Health Care Initiative

  Recent Webinar: Perspectives in Health: Biotechnology Funding and the Future of Therapeutics

  Professor Amitabh Chandra had a great conversation with Katrine Bosley on the explosion of new ideas, capital strategy in Life Sciences and the implications this has on the next generation of therapeutics.
• 

  • 18 June 2021
  • HBS Health Care Initiative

  Recent Webinar: Perspectives in Health: Define Ventures – The Future of Digital Health Investing and the Impact of Medical-Technology Entrepreneurs

  Professor Ariel Stern had an engaging discussion with Lynne Chou O’Keefe (MBA 2005), Founder of Define Ventures. They delved into the strategy of Define Ventures’ $200m early-stage digital health fund focused on incubation, seed, and series A & B investment opportunities in digital health.
• 

  • 14 June 2021
  • HBS Health Care Initiative

  Recent Webinar: Perspectives in Health: Making Health Care More Equitable, Just, and Effective

  Professor Rob Huckman spoke with Lloyd Dean, CEO of CommonSpirit Health and Kevin Lofton, CEO emeritus of CommonSpirit Health about building healthier communities, advocating for those who are poor and vulnerable, and innovating how and where healing can happen—both inside their hospitals and out in the community.
• 

  • 01 Feb 2021
  • Kraft Precision Medicine Accelerator

  Disparities: Activating The Right Strategy Finding Cures For All

  During the past year, the topic of disparities has been prioritized by nonprofit leaders. Learn more about the two major issues related to disparities that were assessed during the HBS Kraft Leadership Forum on December 16, 2020: 1.) Enrolling representative patient populations in clinical trials and patient registries, and 2.) Leveraging patient data to better understand disparities and gaps.